| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| KILAR JASON | Director | C/O WEALTHFRONT CORPORATION, 261 HAMILTON AVENUE, PALO ALTO | /s/ Lauren Lin, as Attorney-in-Fact | 15 Dec 2025 | 0001239764 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WLTH | Common Stock | Options Exercise | $167,000 | +100,000 | $1.67 | 100,000 | 15 Oct 2025 | Direct | F1 | |
| transaction | WLTH | Common Stock | Options Exercise | $232,000 | +200,000 | +200% | $1.16 | 300,000 | 15 Oct 2025 | Direct | F1 |
| transaction | WLTH | Common Stock | Options Exercise | $0 | +258,981 | +86% | $0.000000 | 558,981 | 11 Dec 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WLTH | Stock Option (Right to Buy) | Options Exercise | $0 | -100,000 | -100% | $0.000000 | 0 | 15 Oct 2025 | Common Stock | 100,000 | $1.67 | Direct | F1, F2 |
| transaction | WLTH | Stock Option (Right to Buy) | Options Exercise | $0 | -200,000 | -100% | $0.000000 | 0 | 15 Oct 2025 | Common Stock | 200,000 | $1.16 | Direct | F1, F3 |
| transaction | WLTH | Restricted Stock Units | Options Exercise | $0 | -258,981 | -69% | $0.000000 | 117,719 | 11 Dec 2025 | Common Stock | 258,981 | Direct | F4, F5, F6 |
| Id | Content |
|---|---|
| F1 | The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering ("IPO"), and the transaction is reported herein pursuant to Rule 16a-2(a). The reported transaction is an exempt transaction with the Issuer. |
| F2 | The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on October 10, 2021. |
| F3 | The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on May 14, 2024. |
| F4 | Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| F5 | The award was granted subject to a performance-based vesting condition which was satisfied in connection with the Issuer's initial public offering ("IPO"), as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO. |
| F6 | These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. |